Skip to main content
. 2016 Jul 13;2016:5297329. doi: 10.1155/2016/5297329

Table 3.

Detection of EGFR mutations from tissue and plasma samples.

N (%) Tissue  Plasma Tissue
Before treatment Before treatment
P0 (%)
Under treatment
P1 (%)
After PD
P2 (%)
After PD
Number of samples 24 24 23 16 3
Activating mutation 24 19 (79.2) 6 (26.1) 11 (68.8) 3 (100)
Drug-resistant mutation (T790M) NA 2 (8.3) 4 (17.4) 8 (50.0) 3 (100)